Katoh Kimihiko | Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital

スポンサーリンク

概要

関連著者

もっと見る

著作論文

PE-237 Comparison of Therapeutic Strategy for the Treatment of Sirolimus-Eluting Stent Restenosis(PE040,Coronary Revascularization, PCI (Restenosis/Others) 2 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Soc
Association of candidate gene polymorphisms with chronic kidney disease in Japanese individuals with hypertension
PJ-437 Genetic Factors for Ischemic and Hemorrhagic Stroke in Japanese Individuals(PJ074,Cerebrovascular Circulation/Stroke (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
DPE-004 Associations of Genetic Variants with Ischemic Stroke in Japanese Individuals with Metabolic Syndrome(DPE01,Metabolic Syndrome (H),Digital Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PJ-523 Adiponectin Predicts Cardiac Mortality and Left Ventricular Dysfunction after Acute Myocardial Infarction(PJ088,ACS/AMI (Clinical/Pathophysiology) 2 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Soci
PJ-037 The Relationship between Rate of Change of HDL Cholesterol and Cardiac Events in Patients Taking Strong Statins after Elective PCI(PJ006,Lipid Disorders (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation So
PE-544 Associations of Genetic Variants with Myocardial Infarction in Japanese Individuals with Chronic Kidney Disease(PE091,Molecular Biology (M),Poster Session (English),The 73rd Annual Scientific Meeting of the Japanese Circulation Society)
OJ-214 Statin and Angiotensin-Converting Enzyme Inhibitor Improve Endothelial Cell Function in Patients after Acute Myocardial Infarction(OJ36,Peripheral Circulation/Vascular Disease (Therapy) 2 (H),Oral Presentation (Japanese),The 73rd Annual Scientific
OJ-164 Association of a Polymorphism of the Apolipoprotein E Gene with Chronic Kidney Disease in Japanese Individuals with Metabolic Syndrome(OJ28,Kidney/Renal Circulation/CKD 1 (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Ja
OJ-163 Association of Genetic Variants with Chronic Kidney Disease in Japanese Individuals(OJ28,Kidney/Renal Circulation/CKD 1 (H),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
OJ-127 Matrix Metalloproteinase-2 Predicts Cardiac Mortality and Heart Failure Hospitalization after Acute Myocardial Infarction(OJ22,ACS/AMI (Clinical/Pathophysiology) (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of The Japanese
OE-203 Identification of Polymorphisms of the Apolipoprotein A-V Gene as Genetic Risk Factors for Metabolic Syndrome(OE35,Metabolic Syndrome (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
PJ-807 A Pathophysiologic Study of Tako-Tsubo Cardiomyopathy with F-18 Fluorodeoxyglucose Positron Emission Tomography(Cardiomyopathy, basic / clinical(07)(M),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
PJ-768 Matrix Metalloproteinase-2 and Tissue Inhibitor Matrix Metalloproteinase-2 Predict Left Ventricular Remodeling 6 months After Acute Myocardial Infarction(Acute myocardial infarction, clinical(pathophysiology)(03)(IHD),Poster Session(Japanese),The 7
PE-352 Genetic Risk for low HDL-cholesterol or high LDL-cholesterol Concentrations(Lipid disorders(03)(H),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
PE-139 Impact of Matrix metalloproteinase-2 Levels on Long-term Results Following Pharmacological or Electrical Cardioversion in Patients with Atrial Fibrillation(Arrhythmia, therapy(07)(A),Poster Session(English),The 72nd Annual Scientific Meeting of the
OJ-254 Assessment of Genetic Factors for Obesity(Diabetes / Obesity / Metabolic syndrome(03)(H),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-331 Association of Polymorphisms of ABCA1 and ROS1 with Hypertension in Japanese Individuals(Hypertension, clinical(02)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-211 Assessment of Genetic Risk for Hypertriglyceridemia(Lipid disorders(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-073 Assessment of Genetic Risk for Thoracic Aortic Aneurysm among Hypertensive Patients(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
OE-072 Genetic Risk for Myocardial Infarction in Japanese Indivisuals(Heart failure, clinical(01)(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
FRS-090 Genetic Risk for Metabolic Sndrome : Examination of Canditate Gene Polymorphisms related to Lipid Metabolism in Japanese Individuals(New Insights into Metabolic Syndrome(01)(H),Featured Research Session,The 72nd Annual Scientific Meeting of the Ja
OE-210 Mitochondrial Haplogroup N9b is Protective against Myocardial Infarction in Japanese Males(Genetics/Genetically engineered models/Gene therapy-1(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)
OE-207 Association of Gene Polymorphisms with Myocardial Infarction among Men or Women or among Individuals with or without Coronary Risk Factors(Genetics/Genetically engineered models/Gene therapy-1(H/M), The 71st Annual Scientific Meeting of the Japanes
PJ-622 Genetic Risk for Myocardial Infarction in Individuals with Low Serum HDL-Cholesterol Levels(Genetics/Genetically engineered models/Gene therapy-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-557 Prediction of Genetic Risk for Metabolic Syndrome(Preventive medicine/Epidemiology/Education-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-501 Assessment of Genetic Risk for Myocardial Infarction(Genetics/Genetically engineered models/Gene therapy-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PE-500 Genetic Risk for Lone Atrial Fibrillation(Genetics/Genetically engineered models/Gene therapy-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
PJ-497 Tissue Inhibitor of Matrix Metalloproteinase-2 Affects Left Ventricular Diastolic Function after Acute Myocardial Infarction(Heart failure, clinical-14, The 71st Annual Scientific Meeting of the Japanese Circulation Society)

もっと見る

スポンサーリンク